Wallingford, Connecticut, March 6, 2013: Sverica International Management LLC (“Sverica”) announced today that its Fund III acquired Dexmet Corporation (“Dexmet” or the “Company”) on March 1, 2013. Dexmet develops and manufactures highly engineered expanded foils and polymers used in a variety of end markets. The Company provides solutions for a range of mission critical applications, including lightning strike protection for major composite aircraft manufacturers, anodes and cathodes for advanced battery technologies and supportive materials for filtration and automotive applications. It counts as its customers dozens of global blue chip industrial leaders.
Dexmet has established itself as the leading provider of precision expanded materials worldwide and is well-positioned for continued growth moving forward. “This partnership with Sverica comes at an exciting time for Dexmet,” stated Bob Bochman, President of Dexmet. “Sverica shares our long-term view of the considerable market opportunity for Dexmet’s products and will help us become even better strategic partners for our customers.”
Dave Finley, Managing Director at Sverica, added: “We are excited to partner with Bob Bochman and the rest of the Dexmet team. Dexmet will be a great addition to the Sverica portfolio, as the Company fits well with Sverica’s dedicated focus on niche manufacturers of specialty materials with track records of success and demonstrated growth prospects.”
About Dexmet Corporation
Dexmet is a global leader in the development and manufacturing of highly engineered expanded foils and polymeric materials used in aerospace, battery, industrial, and other applications where precision characteristics are required. With a history dating back to 1948, Dexmet is a pioneer in the development of proprietary material expanding technology and equipment, including industry leading thinness and widths for product-specific applications. Dexmet partners and works closely with its customers to stay at the edge of new industrial technologies and applications. Dexmet is headquartered in Wallingford, Connecticut. For more information, please visit www.dexmet.com.